Clinical Trial Update: Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Bryostatin 1 in patients with metastatic or recurrent head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Bryostatin-1 (bryostatin-1)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED